Evidence map›Paper›PMID 28596556›Full record

ArticleScientific reports2017

Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).

Hee Young Kim, Tae-Hyun Yoo, Yuri Hwang, Ga Hye Lee, Bonah Kim, Jiyeon Jang, Hee Tae Yu, Min Chang Kim, Joo-Youn Cho, Chan Joo Lee and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. T-Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. pH regulates gut bacterial tryptophan metabolism.NPJ biofilms and microbiomes · 2026
    Article
  11. Kidney Disease as a Driver of Immunosenescence: Mechanisms and Potential Interventions.Journal of the American Society of Nephrology : JASN · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hee Young KimDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
Tae-Hyun YooDivision of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Yuri HwangDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
Ga Hye LeeBK21Plus Biomedical Science Project, Seoul National University College of Medicine, Seoul, South Korea.
Bonah KimBK21Plus Biomedical Science Project, Seoul National University College of Medicine, Seoul, South Korea.
Jiyeon JangDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
Hee Tae YuDivision of Cardiology, Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Min Chang KimDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.ORCID 0000-0001-8555-8895
Joo-Youn ChoDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.ORCID 0000-0001-9270-8273
Chan Joo LeeDepartment of Health Promotion and Disease Prevention, Severance Hospital, Seoul, South Korea.
Hyeon Chang KimCardiovascular and Metabolic Diseases Etiology Research Center and Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-7867-1240
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea. shpark0530@yuhs.ac.
Won-Woo LeeDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea. wonwoolee@snu.ac.kr.ORCID 0000-0002-5347-9591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive renal failure causes uremia-related immune dysfunction, which features a chronic inflammatory milieu. Given the central role of end-stage renal disease (ESRD)-related immune dysfunction in the pathogenesis of cardiovascular diseases (CVDs), much attention has been focused on how uremic toxins affect cellular immunity and the mechanisms underlying pathogenesis of atherosclerosis in ESRD patients. Here, we investigated the characteristics of monocytes and CD4

Indexed as

AdultAgedApoptosisCase-Control StudiesCD4-Positive T-LymphocytesCells, CulturedChemokine CXCL1CX3C Chemokine Receptor 1Endothelium, VascularFemaleHumansHuman Umbilical Vein Endothelial CellsIndicanKidney Failure, ChronicMaleMiddle AgedChemokine CXCL1CX3C Chemokine Receptor 1CX3CR1 protein, humanCXCL1 protein, humanIndicanReceptors, Aryl HydrocarbonTumor Necrosis Factor-alpha

Identifiers

PMID28596556
PMCPMC5465082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.